Stem-cell technology has primarily been the province of small biotechnology companies, such as Geron Corp. of Menlo Park, California and closely held Novocell Inc. of San Diego. Now scientists from Pfizer, working in labs in Cambridge, Massachusetts, and Cambridge, England, will research new treatments to spur stem cells already in people’s bodies to become active in healing,
“The major pharma companies are moving into the field and taking a very strong position,” said Alan Trounson, president of the California Institute of Regenerative Medicine, the state agency that funds stem-cell research. “We feel they’re like big ships coming together with us. It’s starting to be an armada.” Read more here
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
You must log in to post a comment.